1. August, J. T. (1982) Monoclonal Antibodies in Drug Development. Soc. Pharmacol. Exp. Therapeutics, Bethesda, Maryland, pp. 1–237.
2. Bach, J.-F. (1983) The thymus in immunodeficiency diseases: New therapeutic approaches. Birth Defects: Original Article Series
1, 245–253.
3. Bach, J-F. and Chatenoud, L. (1982) The significance of T-cell subsets defined by monoclonal antibodies in human diseases. Ann. Immunol. Inst. Pasteur
183D, 131–136.
4. Bernstein, I. D. and Nowinski, R. C. (1982) Monoclonal Antibody Treatment of Transplanted and Spontaneous Murine Leukemia, in Hybridomas in Cancer Diagnosis and Treatment ( Mitchell, M. S. and Oettgen, H. F., eds.) Raven, New York.
5. Cheung, N.-K. V., Saannen, U. M., Neely, J. E., Landmeier, B., Donovan, D., and Coccia, P. F. (1985) Monoclonal antibodies to a glycolipid antigen on human neuroblastoma cells. Cancer Res. 45, 2642–2649.